Biorem Inc (TSE:BRM)
:BRM
Want to see TSE:BRM full AI Analyst Report?
BRM Stock Chart & Stats
C$2.65
-C$0.02(-0.63%)
At close: 4:00 PM EST
C$2.65
-C$0.02(-0.63%)
Day’s Range― - ―
52-Week RangeC$1.67 - C$3.57
Previous CloseN/A
Volume29.81K
Average Volume (3M)32.44K
Market Cap
C$51.41M
Enterprise ValueC$44.07M
Total Cash (Recent Filing)C$9.99M
Total Debt (Recent Filing)C$2.65M
Price to Earnings (P/E)49.3
Beta0.52
Next Earnings
Aug 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.31
Shares Outstanding16,217,028
10 Day Avg. Volume30,537
30 Day Avg. Volume32,440
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)2.90
Price to Sales (P/S)1.02
P/FCF Ratio5.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.28
Revenue Forecast (FY)C$45.20M
Bulls Say, Bears Say
Bulls Say
Margin ImprovementSustained margin expansion to mid-teens operating levels materially raises operational resilience. Higher margins improve cash available for reinvestment, support pricing power in engineered solutions, and increase ability to absorb project timing volatility while funding growth initiatives.
De-risked Balance SheetLow leverage and a stronger equity base provide durable financial flexibility for project-backed sales cycles. Reduced interest burden and higher solvency help the company fund working capital swings, bid on larger contracts, and pursue strategic investments without pressuring operations.
Revenue Recovery TrendRecovery after a downturn indicates demand resilience for air-treatment systems. Consistent new installations plus an installed base support recurring aftermarket service revenue, which underpins long-term cash flow potential and steadier lifetime customer value.
Bears Say
Cash-Flow VolatilityLarge year-over-year free cash flow deterioration signals working-capital or timing swings that can strain execution on multi-phase projects. Persistent cash volatility limits reinvestment capacity, increases reliance on external financing, and complicates reliable funding for growth or service programs.
Choppy Demand & GrowthIrregular, modest top-line growth reflects sensitivity to municipal/industrial capex cycles and project timing. This variability makes forecasting and capacity planning harder, may pressure utilization and fixed-cost absorption, and can delay steady margin and cash-flow improvement.
ROE SensitivityVery high ROE can mask fragility: if earnings revert to mean, returns could fall sharply, revealing sensitivity to revenue or margin shifts. Dependence on elevated ROE raises stakeholder risk if project timing, pricing competitiveness, or aftermarket volumes weaken.
Biorem Inc News
BRM FAQ
What was Biorem Inc’s price range in the past 12 months?
Biorem Inc lowest stock price was C$1.67 and its highest was C$3.57 in the past 12 months.
What is Biorem Inc’s market cap?
Biorem Inc’s market cap is C$51.41M.
When is Biorem Inc’s upcoming earnings report date?
Biorem Inc’s upcoming earnings report date is Aug 25, 2026 which is in 96 days.
How were Biorem Inc’s earnings last quarter?
Currently, no data Available
Is Biorem Inc overvalued?
According to Wall Street analysts Biorem Inc’s price is currently Overvalued.
Does Biorem Inc pay dividends?
Biorem Inc does not currently pay dividends.
What is Biorem Inc’s EPS estimate?
Biorem Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biorem Inc have?
Biorem Inc has 16,217,028 shares outstanding.
What happened to Biorem Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biorem Inc?
Currently, no hedge funds are holding shares in TSE:BRM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Biorem Inc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.30%
12-Months-Change
Fundamentals
Return on Equity
37.34%
Trailing 12-Months
Asset Growth
11.97%
Trailing 12-Months
Company Description
Biorem Inc
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.
Technical Analysis
Dundee Sustainable Technologies
―
Sharc International Systems Inc
―
Questor Technology
―
Thermal Energy International
―
Greenlane Renewables Inc
―
Options Prices
Currently, No data available
---